Zoekresultaten - 39 results
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
Genotyping Tests) project. This panel consisted of cervical specimens from approximately 1,000 women attending routine screening, “enriched” with 300 women with abnormal cytology. Cases were defined as women ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
identify studies that used PCR for detection of HPV DNA in head and neck squamous cell carcinomas with information about HPV genotype distribution. We included studies that tested 20 or more biopsies per ...
Cytological screening for cervical cancer in the province of Limburg, Belgium.
Prev, Volume 20, Issue 1, p.18-24 (2011) Keywords: Adult Belgium Female Humans Mass Screening middle aged Neoplasms, Squamous Cell Papanicolaou Test REGISTRIES Uterine Cervical Neoplasms Vaginal Smears ...
Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening.
screening cervical cancer HPV Abstract: Key Findings HPV testing is more sensitive for precancerous lesions CIN2 and CIN3 than cytology. The downside is that the transversal specificity is lower. The ...
IPAAC Rapport WP4: Cancer control policy interview survey
screening, the extent of implementation of screening programs varies widely among EU Member States. The most often reported challenges concern test selection, non-appropriate governance and/or legal frameworks ...
Chapter 10: HPV testing on cervical cancer specimens: which assay can be used in cervical cancer screening.
screening programmes need to know which HPV tests are credible and have evidence-based performance in primary screening. Systematic reviews have assessed which high-risk HPV DNA tests are sufficiently ...
Thyroid Cancer Incidence around the Belgian Nuclear Sites, 2000-2014.
hypothesis tests and generalized additive models were performed to test the hypothesis of a gradient in thyroid cancer incidence with increasing levels of surrogate exposures. Residential proximity to the ...
Clinical Guidance: Supporting the introduction of the HPV test in cervical cancer screening in Belgium
RNA-based HPV testing. The screening for cervical cancer in Belgium was performed until the end of 2024 by a 3-yearly cytological examination of a cervical smear. The HPV test was reimbursed only after an ...
Wetenschappelijke richtlijn: Ter ondersteuning van de invoering van de HPV-test voor screening naar baarmoederhalkanker in België
tot eind 2024 uitgevoerd door middel van een 3-jaarlijks cytologisch onderzoek van een baarmoederhalsuitstrijkje. De HPV-test werd slechts terugbetaald na een afwijkend cytologieresultaat. In december ...